The Global Transplant Diagnostics Market is touted to scale the valuation of USD 2,074.65 million during the forecast period (2018-2023). Technological advancements have reduced the healthcare cost and have taken the medical industry miles ahead by helping researchers and doctors in implementing new methods to cure patients. Consequently, this is also going to aid the market in achieving a splendid CAGR of 7.81% by 2023.
Rapid urbanization, along with industrialization moving at express speed, has given rise to expendable incomes among patients. Well-being awareness among the populace has also increased. Thus, as a resultant factor, increase in investment in this sector can be witnessed. People are now more willing to improve the quality of their lives by getting transplantation of numerous human cells, tissues, and organs.
Get Free Sample @ https://www.marketresearchfuture.com/sample_request/1324
According to reports published, in collaboration, by World Health Organization (WHO) and Spain-based Organización Nacional de Trasplantes (ONT), 126,670 organs were transplanted in 2015, of which 41.80% was of the kidney category. In North America, the number was around an astounding 19,484 in 2017. The staggering numbers reveal a much more comprehensive picture of the market and promise future prosperity.
With rising population, critical diseases are also experiencing a surge, which as an upshot is triggering increasing cases of organ failures. For instance, renal diseases can occur due to high blood pressure and diabetes and as a corollary effect, kidney transplant or dialysis becomes imperative.
Global Transplant Diagnostics Market – Key Players
- Thermo Fisher Scientific, Inc. (US)
- Bio-Rad Laboratories, Inc. (US)
- F. Hoffman-La Roche Ltd. (Switzerland)
- Becton Dickinson and Company (US)
- Abbott Laboratories Inc (US)
- CareDx (US)
- Qiagen N.V. (Netherlands)
- Immucor, Inc. (US)
- GenDx (Netherlands)
- Omixon Ltd. (UK)
- bioMérieux S.A. (France)
- Illumina, Inc. (US)
- Immucor Transplant Diagnostics, Inc (US)
- Affymetrix, Inc (US)
- Linkage Biosciences (US)
In April 2019
Researchers from the Bologna University Hospital, Italy, claimed that their new method could predict rejection in heart transplant cases more accurately. This new method is expected to use Gene Expression Profiling (GEP) techniques. It would be guided by patented technology called Molecular Microscope Diagnostic System (MMDx). This algorithm was originally developed for kidney transplantation and is getting validation for heart diagnostics as well.
Get Discount on Report @ https://www.marketresearchfuture.com/check-discount/1324
Global Transplant Diagnostics Market – Segmentation
The Global Transplant Diagnostics Market can be segmented by product and service, screening type, organ type, application, and end-users.
Based on the product & service, the transplant diagnostics market includes reagents & consumables, instruments, and software & services. The reagents and consumables segment were the market leader in 2017 and will remain lucrative during the forecast period.
Based on the screening type, the transplant diagnostics market comprises pre-transplant screening and post-transplant screening. Several organs such as lung, pancreas, heart, liver, kidney, and others can be screened by following diagnostic methods.
Application-wise, the transplant diagnostics market can be segmented into research applications, diagnostic applications, and others.
Based on the end-users, the transplant diagnostics market includes research laboratories & academic institutes, commercial service providers, hospitals & transplant centers, and others. The hospitals and transplant centers segment are expected to retain their top position till the end of the forecast period owing to infrastructural benefits.
Global Transplant Diagnostics Market – Regional Analysis
Region-specific analysis of the global market includes the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).
The Americas have the maximum market claim, and this is owing to their superior infrastructure and robust healthcare sector. This kind of foundation has enabled the region in accepting latest technologies quite quickly and provides an edge over the rest. The regional market is benefitting from researches as well that are getting funded constantly by government and several private investors. At the same time, high investment capacity is giving the market substantial opportunity.
Europe’s market is getting much prominence due to the inclusion of robot-assisted laboratory automation. Its significant growth in human leukocyte antigen (HLA) typing is also helping the market in moving forward.
The APAC market has emerged as an important region and the credit goes to its huge population and emerging economies providing substantial traction by overhauling their outdated infrastructure. At the same time, governments have realized the importance of diagnosing organs beforehand to save them from getting wasted.
The MEA Transplant Diagnostics Market is developing their healthcare infrastructure substantially, especially in the Middle East zone. This includes countries such as Saudi Arabia, Qatar, Dubai, and others. The investment made by governments for such projects are quite high. However, the market in Africa is lacking from the presence of several poor economies.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar